Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study - Quiz - MDSpire

Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study

  • By

  • Chantal F Ski

  • Catriona S Jennings

  • Dirk De Bacquer

  • Kornelia Kotseva

  • John William McEvoy

  • Guy De Backer

  • Iris Erlund

  • Sandra Ganly

  • Terhi Vihervaara

  • Gregory Yoke Hong Lip

  • Kausik K Ray

  • Lars Rydén

  • Agnieszka Adamska

  • Ana Abreu

  • Wael Almahmeed

  • Ade Meidian Ambari

  • Junbo Ge

  • Hosam Hasan-Ali

  • Yong Huo

  • Piotr Jankowski

  • Rodney M Jimenez

  • Yong Li

  • Ahmad Syadi Mahmood Zuhdi

  • Abel Makubi

  • Amam Chinyere Mbakwem

  • Lilian Mbau

  • Jose Luis Navarro Estrada

  • Okechukwu Samuel Ogah

  • Elijah Nyainda Ogola

  • Adalberto Quintero-Baiz

  • Mahmoud Umar Sani

  • Maria Ines Sosa Liprandi

  • Jack Wei Chieh Tan

  • Miguel Alberto Urina Triana

  • Tee Joo Yeo

  • David A Wood

  • David R Thompson

  • on behalf of the INTERASPIRE Investigators

  • November 13, 2025

  • 0 min

Share

Original Source(s)

Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study

  • by Chantal F Ski, Catriona S Jennings, Dirk De Bacquer, Kornelia Kotseva, John William McEvoy, Guy De Backer, Iris Erlund, Sandra Ganly, Terhi Vihervaara, Gregory Yoke Hong Lip, Kausik K Ray, Lars Rydén, Agnieszka Adamska, Ana Abreu, Wael Almahmeed, Ade Meidian Ambari, Junbo Ge, Hosam Hasan-Ali, Yong Huo, Piotr Jankowski, Rodney M Jimenez, Yong Li, Ahmad Syadi Mahmood Zuhdi, Abel Makubi, Amam Chinyere Mbakwem, Lilian Mbau, Jose Luis Navarro Estrada, Okechukwu Samuel Ogah, Elijah Nyainda Ogola, Adalberto Quintero-Baiz, Mahmoud Umar Sani, Maria Ines Sosa Liprandi, Jack Wei Chieh Tan, Miguel Alberto Urina Triana, Tee Joo Yeo, David A Wood, David R Thompson, on behalf of the INTERASPIRE Investigators

  • November 13, 2025

Related Content

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

FDA Broadens Pitolisant Label

The US Food and Drug Administration approves pitolisant (WAKIX) tablets for the treatment of cataplexy in pediatric patients aged 6 years and older with narcolepsy.